Glucose Regulates the Expression of the Apolipoprotein A5 Gene

Journal of Molecular Biology

Volumn 380, Issue 5, 2008, Pages 789-798

  Nowak, Maxime ^a,b,c   Helleboid Chapman, Audrey ^a,b,c   Jakel, Heidelinde ^a,b,c   Moitrot, Emmanuelle ^a,b,c   Rommens, Corinne ^a,b,c   Pennacchio, Len A ^d   Fruchart Najib, Jamila ^c   Fruchart, Jean Charles ^a,b,c  

^a INSTITUT PASTEUR DE LILLE   (France)

^b INSERM   (France)

^c UNIV LILLE   (France)

^d DOE JOINT GENOME INSTITUTE   (United States)

Author keywords

apolipoprotein A5; cardiovascular disease; gene regulation; glucose; USF

Indexed keywords

APOLIPOPROTEIN A5; GLUCOSE DERIVATIVE; MESSENGER RNA; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; SMALL INTERFERING RNA; UPSTREAM STIMULATORY FACTOR 1; UPSTREAM STIMULATORY FACTOR 2;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; E BOX ELEMENT; ENZYME ACTIVATION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; GLUCOSE HOMEOSTASIS; GLYCOLYSIS; HUMAN; HUMAN CELL; LIVER CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

MUS;

EID: 45849117940     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2008.04.057     Document Type: Article

References (47)

1. Breslow J.L. Apolipoprotein genetic variation and human disease. Physiol. Rev. 68 (1988) 85-132
2. Zannis, V. I., & Breslow, J. L. (1985). Genetic mutations affecting human lipoprotein metabolism. Adv. Hum. Genet. 14, 125-215, 383-386.
3. Pennacchio L.A., Olivier M., Hubacek J.A., Cohen J.C., Cox D.R., Fruchart J.C., et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294 (2001) 169-173
4. van der Vliet H.N., Sammels M.G., Leegwater A.C., Levels J.H., Reitsma P.H., et al. Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration. J. Biol. Chem. 276 (2001) 44512-44520
5. van der Vliet H.N., Schaap F.G., Levels J.H., Ottenhoff R., Looije N., Wesseling J.G., et al. Adenoviral overexpression of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in mice. Biochem. Biophys. Res. Commun. 295 (2002) 1156-1159
6. Pennacchio L.A., Olivier M., Hubacek J.A., Krauss R.M., Rubin E.M., and Cohen J.C. Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum. Mol. Genet. 11 (2002) 3031-3038
7. Ribalta J., Figuera L., Fernandez-Ballart J., Vilella E., Castro Cabezas M., Masana L., and Joven J. Newly identified apolipoprotein AV gene predisposes to high plasma triglycerides in familial combined hyperlipidemia. Clin. Chem. 48 (2002) 1597-1600
8. Hubacek J.A., Skodova Z., Adamkova V., Lanska V., and Poledne R. The influence of APOAV polymorphisms (T-1131 > C and S19 > W) on plasma triglyceride levels and risk of myocardial infarction. Clin. Genet. 65 (2004) 126-130
9. Lai C.Q., Demissie S., Cupples L.A., Zhu Y., Adiconis X., Parnell L.D., et al. Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study. J. Lipid Res. 45 (2004) 2096-2105
10. Fruchart-Najib J., Bauge E., Niculescu L.S., Pham T., Thomas B., Rommens C., et al. Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5. Biochem. Biophys. Res. Commun. 319 (2004) 397-404
11. Merkel M., Loeffler B., Kluger M., Fabig N., Geppert G., Pennacchio L.A., et al. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase. J. Biol. Chem. 280 (2005) 21553-21560
12. Oliva C.P., Pisciotta L., Li Volti G., Sambataro M.P., Cantafora A., Bellocchio A., et al. Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 411-417
13. Vu-Dac N., Gervois P., Jakel H., Nowak M., Bauge E., Dehondt H., et al. Apolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor alpha activators. J. Biol. Chem. 278 (2003) 17982-17985
14. Prieur X., Coste H., and Rodriguez J.C. The human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-alpha and contains a novel farnesoid X-activated receptor response element. J. Biol. Chem. 278 (2003) 25468-25480
15. Genoux A., Dehondt H., Helleboid-Chapman A., Duhem C., Hum D.W., Martin G., et al. Transcriptional regulation of apolipoprotein A5 gene expression by the nuclear receptor RORalpha. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 1186-1192
16. Lind U., Nilsson T., McPheat J., Stromstedt P.E., Bamberg K., Balendran C., and Kang D. Identification of the human ApoAV gene as a novel RORalpha target gene. Biochem. Biophys. Res. Commun. 330 (2005) 233-241
17. Jakel H., Nowak M., Moitrot E., Dehondt H., Hum D.W., Pennacchio L.A., et al. The liver X receptor ligand T0901317 down-regulates APOA5 gene expression through activation of SREBP-1c. J. Biol. Chem. 279 (2004) 45462-45469
18. Nowak M., Helleboid-Chapman A., Jakel H., Martin G., Duran-Sandoval D., Staels B., et al. Insulin-mediated down-regulation of apolipoprotein A5 gene expression through the phosphatidylinositol 3-kinase pathway: role of upstream stimulatory factor. Mol. Cell Biol. 25 (2005) 1537-1548
19. Prieur X., Huby T., Coste H., Schaap F.G., Chapman M.J., and Rodriguez J.C. Thyroid hormone regulates the hypotriglyceridemic gene APOA5. J. Biol. Chem. 280 (2005) 27533-27543
20. Miller G.J., and Miller N.E. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet 1 (1975) 16-19
21. Cheung M.C., Brown B.G., Wolf A.C., and Albers J.J. Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease. J. Lipid Res. 32 (1991) 383-394
22. Doiron B., Cuif M.H., Chen R., and Kahn A. Transcriptional glucose signaling through the glucose response element is mediated by the pentose phosphate pathway. J. Biol. Chem. 271 (1996) 5321-5324
23. Foufelle F., Gouhot B., Pegorier J.P., Perdereau D., Girard J., and Ferre P. Glucose stimulation of lipogenic enzyme gene expression in cultured white adipose tissue. A role for glucose 6-phosphate. J. Biol. Chem. 267 (1992) 20543-20546
24. Kabashima T., Kawaguchi T., Wadzinski B.E., and Uyeda K. Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver. Proc. Natl Acad. Sci. USA 100 (2003) 5107-5112
25. Massillon D., Chen W., Barzilai N., Prus-Wertheimer D., Hawkins M., Liu R., et al. Carbon flux via the pentose phosphate pathway regulates the hepatic expression of the glucose-6-phosphatase and phosphoenolpyruvate carboxykinase genes in conscious rats. J. Biol. Chem. 273 (1998) 228-234
26. Kahn A. Transcriptional regulation by glucose in the liver. Biochimie 79 (1997) 113-118
27. Lefrancois-Martinez A.M., Martinez A., Antoine B., Raymondjean M., and Kahn A. Upstream stimulatory factor proteins are major components of the glucose response complex of the L-type pyruvate kinase gene promoter. J. Biol. Chem. 270 (1995) 2640-2643
28. Hasty A.H., Shimano H., Yahagi N., Amemiya-Kudo M., Perrey S., Yoshikawa T., et al. Sterol regulatory element-binding protein-1 is regulated by glucose at the transcriptional level. J. Biol. Chem. 275 (2000) 31069-31077
29. Foufelle F., and Ferre P. New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c. Biochem. J. 366 (2002) 377-391
30. Lou D.Q., Tannour M., Selig L., Thomas D., Kahn A., and Vasseur-Cognet M. Chicken ovalbumin upstream promoter-transcription factor II, a new partner of the glucose response element of the L-type pyruvate kinase gene, acts as an inhibitor of the glucose response. J. Biol. Chem. 274 (1999) 28385-28394
31. Kaytor E.N., Shih H., and Towle H.C. Carbohydrate regulation of hepatic gene expression. Evidence against a role for the upstream stimulatory factor. J. Biol. Chem. 272 (1997) 7525-7531
32. da Silva Xavier G., Rutter G.A., Diraison F., Andreolas C., and Leclerc I. ChREBP binding to fatty acid synthase and L-type pyruvate kinase genes is stimulated by glucose in pancreatic {beta}-cells. J. Lipid Res. 47 (2006) 2482-2491
33. Wang H., and Wollheim C.B. ChREBP rather than USF2 regulates glucose stimulation of endogenous L-pyruvate kinase expression in insulin-secreting cells. J. Biol. Chem. 277 (2002) 32746-32752
34. Chen M., Breslow J.L., Li W., and Leff T. Transcriptional regulation of the apoC-III gene by insulin in diabetic mice: correlation with changes in plasma triglyceride levels. J. Lipid Res. 35 (1994) 1918-1924
35. Wang S., Skorczewski J., Feng X., Mei L., and Murphy-Ullrich J.E. Glucose up-regulates thrombospondin 1 gene transcription and transforming growth factor-beta activity through antagonism of cGMP-dependent protein kinase repression via upstream stimulatory factor 2. J. Biol. Chem. 279 (2004) 34311-34322
36. Bidder M., Shao J.S., Charlton-Kachigian N., Loewy A.P., Semenkovich C.F., and Towler D.A. Osteopontin transcription in aortic vascular smooth muscle cells is controlled by glucose-regulated upstream stimulatory factor and activator protein-1 activities. J. Biol. Chem. 277 (2002) 44485-44496
37. Wang D., and Sul H.S. Upstream stimulatory factors bind to insulin response sequence of the fatty acid synthase promoter, USF1 is regulated. J. Biol. Chem. 270 (1995) 28716-28722
38. Weigert C., Brodbeck K., Sawadogo M., Haring H.U., and Schleicher E.D. Upstream stimulatory factor (USF) proteins induce human TGF-beta1 gene activation via the glucose-response element - 1013/- 1002 in mesangial cells: up-regulation of USF activity by the hexosamine biosynthetic pathway. J. Biol. Chem. 279 (2004) 15908-15915
39. Kaytor E.N., Qian J., Towle H.C., and Olson L.K. An indirect role for upstream stimulatory factor in glucose-mediated induction of pyruvate kinase and S14 gene expression. Mol. Cell Biochem. 210 (2000) 13-21
40. Kennedy H.J., Viollet B., Rafiq I., Kahn A., and Rutter G.A. Upstream stimulatory factor-2 (USF2) activity is required for glucose stimulation of L-pyruvate kinase promoter activity in single living islet beta-cells. J. Biol. Chem. 272 (1997) 20636-20640
41. Vallet V.S., Casado M., Henrion A.A., Bucchini D., Raymondjean M., Kahn A., and Vaulont S. Differential roles of upstream stimulatory factors 1 and 2 in the transcriptional response of liver genes to glucose. J. Biol. Chem. 273 (1998) 20175-20179
42. Vallet V.S., Henrion A.A., Bucchini D., Casado M., Raymondjean M., Kahn A., and Vaulont S. Glucose-dependent liver gene expression in upstream stimulatory factor 2 -/- mice. J. Biol. Chem. 272 (1997) 21944-21949
43. Kawaguchi T., Takenoshita M., Kabashima T., and Uyeda K. Glucose and cAMP regulate the L-type pyruvate kinase gene by phosphorylation/dephosphorylation of the carbohydrate response element binding protein. Proc. Natl Acad. Sci. USA 98 (2001) 13710-13715
44. Yamashita H., Takenoshita M., Sakurai M., Bruick R.K., Henzel W.J., Shillinglaw W., et al. A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc. Natl Acad. Sci. USA 98 (2001) 9116-9121
45. Dentin R., Pegorier J.P., Benhamed F., Foufelle F., Ferre P., Fauveau V., et al. Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression. J. Biol. Chem. 279 (2004) 20314-20326
46. Stoeckman A.K., Ma L., and Towle H.C. Mlx is the functional heteromeric partner of the carbohydrate response element-binding protein in glucose regulation of lipogenic enzyme genes. J. Biol. Chem. 279 (2004) 15662-15669
47. Ma L., Robinson L.N., and Towle H.C. ChREBP*Mlx is the principal mediator of glucose-induced gene expression in the liver. J. Biol. Chem. 281 (2006) 28721-28730